Does SECUKINUMAB Cause Oral candidiasis? 520 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 520 reports of Oral candidiasis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.3% of all adverse event reports for SECUKINUMAB.
520
Reports of Oral candidiasis with SECUKINUMAB
0.3%
of all SECUKINUMAB reports
5
Deaths
96
Hospitalizations
How Dangerous Is Oral candidiasis From SECUKINUMAB?
Of the 520 reports, 5 (1.0%) resulted in death, 96 (18.5%) required hospitalization, and 22 (4.2%) were considered life-threatening.
Is Oral candidiasis Listed in the Official Label?
Yes, Oral candidiasis is listed as a known adverse reaction in the official FDA drug label for SECUKINUMAB.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Oral candidiasis?
PREDNISONE (581)
ADALIMUMAB (548)
METHOTREXATE (464)
FLUTICASONE\SALMETEROL (402)
INFLIXIMAB (345)
METRONIDAZOLE (327)
SULFAMETHOXAZOLE\TRIMETHOPRIM (323)
METHYLPREDNISOLONE (322)
ACETAMINOPHEN (294)
RITUXIMAB (291)
Which SECUKINUMAB Alternatives Have Lower Oral candidiasis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG